A novel sphingosine kinase inhibitor induces autophagy in tumor cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 2, 2010, Pages 454-464

  Beljanski, Vladimir ^a   Knaak, Christian ^a   Smith, Charles D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 CHLOROPHENYL)ADAMANTANE 1 CARBOXYLIC ACID (PYRIDIN 4 YLMETHYL)AMIDE; 3 METHYLADENINE; ABC 294640; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CISPLATIN; DNA NUCLEOTIDYLEXOTRANSFERASE; GELDANAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST ADENOCARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL DEATH; CELL KILLING; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIGHT CHAIN; LYSOSOME; MOUSE; NICK END LABELING; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN CLEAVAGE; TUMOR CELL; TUMOR XENOGRAFT;

ADAMANTANE; ADENINE; ANIMALS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELL CYCLE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LEUPEPTINS; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL MEMBRANES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; PYRIDINES; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UNFOLDED PROTEIN RESPONSE;

EID: 77951085269     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.163337     Document Type: Article

References (40)

1. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, and Thompson CB (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326-336. (Pubitemid 46203961)
2. Bursch W, Ellinger A, Gerner C, Frohwein U, and Schulte-Hermann R (2000) Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann NY Acad Sci 926:1-12. (Pubitemid 32050138)
3. Cheng TJ, Wang YJ, Kao WW, Chen RJ, and Ho YS (2007) Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid. Food Chem Toxicol 45:1027-1038.
4. Chou TC and Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55.
5. Cui Q, Tashiro S, Onodera S, Minami M, and Ikejima T (2007) Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol Pharm Bull 30:859-864. (Pubitemid 46708626)
6. Cuvillier O (2007) Sphingosine kinase-1: a potential therapeutic target in cancer. Anticancer Drugs 18:105-110. (Pubitemid 44967421)
7. Delgado A, Casas J, Llebaria A, Abad JL, and Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 1758:1957-1977.
8. Ding WX and Yin XM (2008) Sorting, recognition, and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4:141-150.
9. Edwards PA, Tabor D, Kast HR, and Venkateswaran A (2000) Regulation of gene expression by SREBP and SCAP. Biochim Biophys Acta 1529:103-113.
10. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, and Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969. (Pubitemid 37187498)
11. French KJ, Upson JJ, Keller SN, Zhuang Y, Yun JK, and Smith CD (2006) Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 318:596-603. (Pubitemid 44061234)
12. French KJ, Zhuang Y, Maines LW, Gao P, Wang W, Beljanski V, Upson JJ, Green CL, Keller SN and Smith CD (2010) Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J Pharmacol Exp Ther doi:10.124/jpet.109.163444.
13. Fulda S (2009) Tumor resistance to apoptosis. Int J Cancer 124:511-515.
14. Herman-Antosiewicz A, Johnson DE, and Singh SV (2006) Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res 66:5828-5835. (Pubitemid 43927137)
15. Hu X and Xuan Y (2008) Bypassing cancer drug resistance by activating multiple death pathways: a proposal from the study of circumventing cancer drug resistance by induction of necroptosis. Cancer Lett 259:127-137. (Pubitemid 50015326)
16. Igarashi Y, Hakomori S, Toyokuni T, Dean B, Fujita S, Sugimoto M, Ogawa T, el-Ghendy K, and Racker E (1989) Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28:6796-6800.
17. Jin S and White E (2008) Tumor suppression by autophagy through the management of metabolic stress. Autophagy 4:563-566.
18. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151-175. (Pubitemid 351231180)
19. Kundu M and Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annu Rev Pathol 3:427-455. (Pubitemid 351488288)
20. Lavieu G, Scarlatti F, Sala G, Carpentier S, Levade T, Ghidoni R, Botti J, and Codogno P (2006) Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J Biol Chem 281:8518-8527. (Pubitemid 43847954)
21. Lavieu G, Scarlatti F, Sala G, Carpentier S, Levade T, Ghidoni R, Botti J, and Codogno P (2008) Sphingolipids in macroautophagy. Methods Mol Biol 445:159-173.
22. Lefranc F, Facchini V, and Kiss R (2007) Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12:1395-1403.
23. Maines LW, Fitzpatrick LR, French KJ, Zhuang Y, Xia Z, Keller SN, Upson JJ, and Smith CD (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci 53:997-1012.
24. Maines LW, French KJ, Wolpert EB, Antonetti DA, and Smith CD (2006) Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases. Invest Ophthalmol Vis Sci 47:5022-5031.
25. Megidish T, White T, Takio K, Titani K, Igarashi Y, and Hakomori S (1995) The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. Biochem Biophys Res Commun 216:739-747.
26. Meijer AJ and Codogno P (2006) Signaling and autophagy regulation in health, aging, and disease. Mol Aspects Med 27:411-425. (Pubitemid 44466652)
27. Pattingre S, Bauvy C, Carpentier S, Levade T, Levine B, and Codogno P (2009) Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J Biol Chem 284:2719-2728.
28. Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, and Haugland RP (1996) Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44:1363-1372. (Pubitemid 27009082)
29. Raval J, Lyman S, Nitta T, Mohuczy D, Lemasters JJ, Kim JS, and Behrns KE (2006) Basal reactive oxygen species determine the susceptibility to apoptosis in cirrhotic hepatocytes. Free Radic Biol Med 41:1645-1654. (Pubitemid 44634244)
30. Ricci MS and Zong WX (2006) Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11:342-357.
31. Scarlatti F, Bauvy C, Ventruti A, Sala G, Cluzeaud F, Vandewalle A, Ghidoni R, and Codogno P (2004) Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J Biol Chem 279:18384-18391. (Pubitemid 38623254)
32. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112. (Pubitemid 20213250)
33. Smith CD, French KJ, and Zhuang Y (2008) inventors; Apogee Biotechnology Corporation, assignee. Sphingosine kinase inhibitors. U.S. patent 7,338,961. 2008 March 4.
34. Taha TA, Hannun YA, and Obeid LM (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39:113-131.
35. Taha TA, Osta W, Kozhaya L, Bielawski J, Johnson KR, Gillanders WE, Dbaibo GS, Hannun YA, and Obeid LM (2004) Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J Biol Chem 279:20546-20554. (Pubitemid 38623502)
36. Thorburn A (2008) Apoptosis and autophagy: regulatory connections between two supposedly different processes. Apoptosis 13:1-9.
37. Turcotte S, Chan DA, Sutphin PD, Hay MP, Denny WA, and Giaccia AJ (2008) A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 14:90-102. (Pubitemid 351885499)
38. Wang M, Tan W, Zhou J, Leow J, Go M, Lee HS, and Casey PJ (2008) A small-molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biol Chem 283:18678-18684.
39. Wymann MP and Schneiter R (2008) Lipid signaling in disease. Nat Rev Mol Cell Biol 9:162-176.
40. Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, and Lenardo MJ (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304:1500-1502. (Pubitemid 38720930)